R&D efficiency is often calculated through the return on investments made on therapeutic candidates when they reach their commercialization stage and can earn revenue for the company that has developed it.
The most basic way to understand the candidate’s journey through preclinical and clinical development is by assessing the exact parameters of other candidates already in the space. To help pharmaceutical companies evaluate the current scenario of a particular indication, Mechanism of Action, Active Pharmaceutical Ingredient, or a particular Drug candidate, etc. DelveInsight’s insight-packed reports clarify uncertainties and challenge blind spots to provide timely intelligence to the company.
AI-Powered Tools
Two purpose-built platforms bringing AI to markets and public health data.
DelveInsight's revolutionary AI-powered platform transforms how you access pharmaceutical market insights, instantly, intuitively, and intelligently.
7000+
Reports
Live
Updates
AI
Forecasts
DelveInsight's advanced epidemiology database transforms how you access patient population data, making insights faster, smarter, and easier to explore.
500+
Reports
7MM
Coverage
Weekly
REFRESH